DHA Supplements (IMAGE)

University of Kansas

DHA Supplements

Caption

The clinical trial's key finding was that being overweight and obese were associated with the expected higher blood pressure in the placebo group but not in the group whose mothers were assigned to DHA. Obese and overweight children of mothers in the placebo group had a large mean increase of 3.94 mm Hg for systolic BP and 4.97 mm Hg for diastolic BP compared with overweight/obese children of DHA-supplemented mothers. These differences were statistically significant.

Credit

KU News Service / University of Kansas

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.